Raloxifene hydrochloride is an adjuvant antiviral treatment of postmenopausal women with chronic hepatitis C: a randomized trial.
Furusyo N, Ogawa E, Sudoh M, Murata M, Ihara T, Hayashi T, Ikezaki H, Hiramine S, Mukae H, Toyoda K, Taniai H, Okada K, Kainuma M, Kajiwara E, Hayashi J.
Furusyo N, et al. Among authors: hayashi j, hayashi t.
J Hepatol. 2012 Dec;57(6):1186-92. doi: 10.1016/j.jhep.2012.08.003. Epub 2012 Aug 10.
J Hepatol. 2012.
PMID: 22889955
Clinical Trial.